NEW YORK – Thomas Durant is an assistant professor of laboratory medicine at the Yale School of Medicine and medical director of chemical pathology and laboratory information technology at Yale-New Haven Hospital. He is a senior author on a recent paper in Clinical Chemistry looking at how the COVID-19 pandemic has heightened the relevance of IT interoperability for clinical laboratories.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.